ST. PETERSBURG INSTITUTE OF BIOREGULATION AND GERONTOLOGY
St. Petersburg Institute of Bioregulation and Gerontology was established in 1992 and has been engaged in research in bioregulation and gerontology. Its basic task is to introduce into the medical practice the results of 20-year experimental and clinical studies of a new class of medicinal substances – peptide bioregulators, which were created in the Research Laboratory of Bioregulators of the S.M. Kirov Military Medical Academy.
In 2001 the Institute was integrated into the North-Western Branch of the Russian Academy of Medical Sciences.
RESEARCH ACTIVITIES
Fundamental studies, improvement of methods for diagnosis and prognosis of various diseases, development of research and production programmes in bioregulation and gerontology.
Design, clinical study, manufacture and introduction into the clinical practice of medications, state-of-the-art technologies of diagnostics and therapy for the purpose of early diagnostics, prevention and treatment of age-related pathologies.
Propagation of research findings in the field of bioregulation and gerontology (by organizing scientific conferences, publishing research papers etc.).
Presently St. Petersburg Institute of Bioregulation and Gerontology of the North-Western Branch of the Russian Academy of Medical Sciences is the only research institution in the North-Western region of Russia, which is engaged in research on ageing, and at the same time is an active clinical diagnostic center in gerontology and geriatrics.
Staff of the Institute constitutes 150 persons, with 80 researchers among them. The research team of the Institute consists of highly qualified specialists, including 1 Associate Member of the Russian Academy of Medical Sciences, 27 professors and doctors of sciences, 27 candidates of sciences, 9 doctors bearing higher category.
The Institute comprises 15 laboratories, which are united in three major departments: the Department of Biogerontology, the Department of Cell Biology and Pathology, and the Department of Clinical Gerontology and Geriatrics. All laboratories are equipped with modern research facilities, providing for high-quality experimental and clinical studies in genetics, chemistry, biochemistry, immunology, physiology, molecular and cell biology, morphology.
Research efforts of the Institute team are concentrated on the following priority directions: studying the mechanisms of ageing; studying the properties and mechanisms of peptide bioregulators effects; design and introduction into clinical practice of new medicinal substances based on peptide bioregulators; studying the markers for in vivo diagnostics of age-related diseases; exploration of demographic aspects of population ageing.
